Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleTucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsAndrew Brenner